USANA Health Sciences is a packaged foods business based in the US. USANA Health Sciences shares (USNA) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $39.52 – an increase of 0.2% over the previous week. USANA Health Sciences employs 1,800 staff and has a trailing 12-month revenue of around $862 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $39.52 |
|---|---|
| 52-week range | $34.15 - $54.81 |
| 50-day moving average | $37.57 |
| 200-day moving average | $43.54 |
| Wall St. target price | $46.50 |
| PE ratio | 14.4469 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $2.73 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $39.04 from 2024-11-19
| 1 week (2024-11-14) | -1.01% |
|---|---|
| 1 month (2024-10-21) | 11.38% |
| 3 months (2024-08-21) | -2.20% |
| 6 months (2024-05-21) | -21.56% |
| 1 year (2023-11-21) | -16.12% |
|---|---|
| 2 years (2022-11-21) | -27.11% |
| 3 years (2021-11-19) | 102.2 |
| 5 years (2019-11-21) | 71.14 |
Valuing USANA Health Sciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of USANA Health Sciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
USANA Health Sciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, USANA Health Sciences shares trade at around 14x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
USANA Health Sciences's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.2442. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into USANA Health Sciences's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
USANA Health Sciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $95.8 million.
The EBITDA is a measure of a USANA Health Sciences's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $862 million |
|---|---|
| Operating margin TTM | 7.79% |
| Gross profit TTM | $804.7 million |
| Return on assets TTM | 8.09% |
| Return on equity TTM | 10.83% |
| Profit margin | 6.3% |
| Book value | $27.98 |
| Market Capitalization | $751.7 million |
TTM: trailing 12 months
We're not expecting USANA Health Sciences to pay a dividend over the next 12 months.
USANA Health Sciences's shares were split on a 2:1 basis on 22 November 2016 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your USANA Health Sciences shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for USANA Health Sciences shares which in turn could have impacted USANA Health Sciences's share price.
Over the last 12 months, USANA Health Sciences's shares have ranged in value from as little as $34.15 up to $54.81. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while USANA Health Sciences's is 0.888. This would suggest that USANA Health Sciences's shares are less volatile than average (for this exchange).
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.